Functional imaging of membrane potential at the single mitochondrion level: Possible application for diagnosis of human diseases

Mitochondrion

Volumn 11, Issue 5, 2011, Pages 764-773

  Quarato, Giovanni ^a   Piccoli, Claudia ^a   Scrima, Rosella ^a   Capitanio, Nazzareno ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Fluorescence microscopy imaging; Mitochondrial diseases; Mitochondrial membrane potential; Oxidative phosphorylation; Single mitochondria analysis; TMRE

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL FUNCTION; CELL POPULATION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME ASSAY; FLUORESCENCE MICROSCOPY; FUNCTIONAL ASSESSMENT; IMAGE ANALYSIS; IMMOBILIZED CELL; MALE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; RESPIRATORY CHAIN;

ACRIDINE ORANGE; ANIMALS; COLORING AGENTS; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENZYME ASSAYS; HUMANS; LIMIT OF DETECTION; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; MITOCHONDRIA, LIVER; MITOCHONDRIAL DISEASES; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; UNCOUPLING AGENTS;

EID: 79961209872     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2011.06.014     Document Type: Article

References (41)

1. Barrientos A. In vivo and in organello assessment of OXPHOS activities. Methods 2002, 26:307-316.
2. Chen X., Zhong Z., Xu Z., Chen L., Wang Y. 2',7'-Dichlorodihydrofluorescein as a fluorescent probe for reactive oxygen species measurement: forty years of application and controversy. Free. Radic. Res. 2010, 44:587-604.
3. Crimi M., O'Hearn S.F., Wallace D.C., Comi G.P. Molecular research technologies in mitochondrial diseases: the microarray approach. IUBMB Life 2005, 57:811-818.
4. Di Mauro S., Schon E.A. Mitochondrial respiratory chain diseases. N. Engl. J. Med. 2003, 348:2656-2668.
5. DiMauro S., Hirano M. Mitochondrial encephalomyopathies: an update. Neuromuscul. Disord. 2005, 15:276-286.
6. Distelmaier F., Koopman W.J., van den Heuvel L.P., Rodenburg R.J., Mayatepek E., Willems P.H., Smeitink J.A. Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. Brain 2009, 132:833-842.
7. Frezza C., Cipolat S., Scorrano L. Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2007, 2:287-295.
8. Fuller K.M., Arriaga E.A. Advances in the analysis of single mitochondria. Curr. Opin. Biotechnol. 2003, 14:35-41.
9. Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria in cancer cells: what is so special about them?. Trends Cell Biol. 2008, 18:165-173.
10. Houtkooper R.H., Vaz F.M. Cardiolipin, the heart of mitochondrial metabolism. Cell. Mol. Life Sci. 2008, 65:2493-2506.
11. Hsieh C.E., Leith A., Mannella C.A., Frank J., Marko M. Towards high-resolution three-dimensional imaging of native mammalian tissue: electron tomography of frozen-hydrated rat liver sections. J. Struct. Biol. 2006, 153:1-13.
12. Ishikawa K., Koshikawa N., Takenaga K., Nakada K., Hayashi J. Reversible regulation of metastasis by ROS-generating mtDNA mutations. Mitochondrion 2008, 8:339-344.
13. Jonckheere A.I., Huigsloot M., Janssen A.J., Kappen A.J., Smeitink J.A., Rodenburg R.J. High-throughput assay to measure oxygen consumption in digitonin-permeabilized cells of patients with mitochondrial disorders. Clin. Chem. 2010, 56:424-431.
14. Kao M.C., Di Bernardo S., Nakamaru-Ogiso E., Miyoshi H., Matsuno-Yagi A., Yagi T. Characterization of the membrane domain subunit NuoJ (ND6) of the NADH-quinone oxidoreductase from Escherichia coli by chromosomal DNA manipulation. Biochemistry 2005, 44:3562-3571.
15. Kuznetsov A.V., Margreiter R. Heterogeneity of mitochondria and mitochondrial function within cells as another level of mitochondrial complexity. Int. J. Mol. Sci. 2009, 10:1911-1929.
16. Kuznetsov A.V., Veksler V., Gellerich F.N., Saks V., Margreiter R., Kunz W.S. Analysis of mitochondrial function in situ in permeabilized muscle fibers, tissues and cells. Nat. Protoc. 2008, 3:965-976.
17. Lim T.S., Dávila A., Wallace D.C., Burke P. Assessment of mitochondrial membrane potential using an on-chip microelectrode in a microfluidic device. Lab. Chip 2010, 10:1683-1688.
18. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
19. Lucigli S., Hoffmeier K., Carrozzo R., Tessa A., Ludwig B., Santarelli F.M. Introducing a novel human mtDNA mutation into the Paracoccus denitrificans COX I gene explains functional deficits in a patient. Neurogenetics 2006, 7:51-57.
20. Maassen J.A., Janssen G.M., Lemkes H.H. Mitochondrial diabetes mellitus. J. Endocrinol. Invest. 2002, 25:477-484.
21. Mitchell P. Coupling of phosphorylation to electron and hydrogen transfer by a chemi-osmotic type of mechanism. Nature 1961, 191:144-148.
22. Modica-Napolitano J.S., Singh K.K. Mitochondrial dysfunction in cancer. Mitochondrion 2004, 4:755-762.
23. Namslauer I., Brzezinski P. A mitochondrial DNA mutation linked to colon cancer results in proton leaks in cytochrome c oxidase. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3402-3407.
24. Namslauer I., Lee H.J., Gennis R.B., Brzezinski P. A pathogenic mutation in cytochrome c oxidase results in impaired proton pumping while retaining O(2)-reduction activity. Biochim. Biophys. Acta 2010, 1797:550-556.
25. Namslauer I., Dietz M., Brzezinski P. Functional effects of mutations in cytochrome c oxidase related to prostate cancer. Biochim. Biophys. Acta 2011, 10.1016/j.bbabio.02.005.
26. Nicholls D.G. The influence of respiration and ATP hydrolysis on the proton-electrochemical gradient across the inner membrane of rat-liver mitochondria as determined by ion distribution. Eur. J. Biochem. 1974, 50:305-315.
27. Nicholls D.G. The non-Ohmic proton leak-25years on. Biosci. Rep. 1997, 17:251-257.
28. Nicholls D.G., Ferguson S.J. Bioenergetics 3 2002, Academic Press, San Diego CA.
29. Pallotti F., Lenaz G. Isolation and subfractionation of mitochondria from animal cells and tissue culture lines. Meth. Cell. Biol. 2007, 80:3-44.
30. Poulton J., Chiaratti M.R., Meirelles F.V., Kennedy S., Wells D., Holt I.J. Transmission of mitochondrial DNA diseases and ways to prevent them. PLoS Genet. 2010, (6.pii):e1001066.
31. Rodriguez M.E., Azizuddin K., Zhang P., Chiu S.M., Lam M., Kenney M.E., Burda C., Oleinick N.L. Targeting of mitochondria by 10-N-alkyl acridine orange analogues: role of alkyl chain length in determining cellular uptake and localization. Mitochondrion 2008, 8:237-246.
32. Rötig A., Lebon S., Zinovieva E., Mollet J., Sarzi E., Bonnefont J.P., Munnich A. Molecular diagnostics of mitochondrial disorders. Biochim. Biophys. Acta 2004, 1659:129-135.
33. Rustin P., Chretien D., Bourgeron T., Gérard B., Rötig A., Saudubray J.M., Munnich A. Biochemical and molecular investigations in respiratory chain deficiencies. Clin. Chim. Acta 1994, 228:35-51.
34. Saraste M. Oxidative phosphorylation at the fin de siecle. Science 1999, 283:1488-1493.
35. Scaduto R.C., Grotyohann L.W. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys. J. 1999, 76:469-477.
36. Schapira A.H. Mitochondrial disease. Lancet 2006, 368:70-82.
37. Schon E.A., DiMauro S., Hirano M., Gilkerson R.W. Therapeutic prospects for mitochondrial disease. Trends Mol. Med. 2010, 16:268-276.
38. Smeitink J., van den Heuvel L., DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev. Genet. 2001, 2:342-352.
39. Taylor R.W., Schaefer A.M., Barron M.J., McFarland R., Turnbull D.M. The diagnosis of mitochondrial muscle disease. Neuromuscul. Disord. 2004, 14:237-245.
40. Wallace D.C. Diseases of the mitochondrial DNA. Annu. Rev. Biochem. 1992, 61:1175-1212.
41. Ward M.W. Quantitative analysis of membrane potentials. Methods Mol. Biol. 2010, 591:335-351.